| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 04/11/2007 | EP1399444B1 Novel heterocyclic compounds, method for preparing same and use thereof as medicines, in particular as anti-bacterial agents |
| 04/11/2007 | EP1147093B1 Substituted bicyclic derivatives useful as anticancer agents |
| 04/11/2007 | CN1944440A Process for preparing 8-hydroxy quinoline aluminum |
| 04/10/2007 | US7202364 ortho-substituted with a fused (hetero)arylamino group, e.g., carboxymethyl 2-(6-chloro-5-indanylamino)phenylacetate; treatment of COX-2 dependent disorders including rheumatoid arthritis, osteoarthritis, dysmenorrhea, pain, tumors or inflammation |
| 04/10/2007 | US7202258 α- and β-amino acid hydroxyethylamino sulfamic acid derivatives useful as retroviral protease inhibitors |
| 04/10/2007 | US7202257 Ureas 1-substituted with a 5 member nitrogen-containing ring in turn substituted with an oxymethylphenyl group and 3-(hetero)aryl-substituted, e.g., 1-{3-tert-butyl-1-[3-(hydroxymethyl)phenyl]-1H-pyrazol-5-yl}-3-(naphthalen-1-yl)urea; used to modulate of the activation state of p38 kinase protein |
| 04/10/2007 | US7202248 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 04/10/2007 | CA2104148C Process for the preparation of substituted benzenes and benzene sulfonic acid and derivatives thereof and a process for the preparation of n,n'-substituted ureas |
| 04/05/2007 | WO2006124874A3 Inhibitors of b-raf kinase |
| 04/05/2007 | US20070078173 Alpha- and beta-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 04/05/2007 | US20070078160 3-[3-(1-Ethyl-4,4,6-trimethyl-2-oxo- 1,2,3,4-tetrahydro-quinolin-7-yl)-4- (2,2,2-trifluoro-ethoxy)-phenyl]- acrylic acid;Retinoid X Receptor (RXR) agonists useful for treating the onset of cancer and metabolic disorders such as diabetes, dyslipidemia, and hypercholesterolemia |
| 04/05/2007 | US20070078159 Has excellent characteristics in terms of physical properties (particularly, dissolution rate) and pharmacokinetics (particularly, bioavailability), and is extremely useful as an angiogenesis inhibitor or c-Kit kinase inhibitor |
| 04/05/2007 | US20070078158 Purification of montelukast |
| 04/05/2007 | US20070078154 Quinoline potassium channel inhibitors |
| 04/05/2007 | US20070078139 Phosphodiesterase 4 inhibitors |
| 04/05/2007 | CA2622000A1 Quinolines and their therapeutic use |
| 04/04/2007 | EP1770085A1 Diamine derivative, process for producing the same and fungicide containing the derivative as active ingredient |
| 04/04/2007 | EP1768973A1 Substituted quinolones |
| 04/04/2007 | EP1224172B1 Drugs for the treatment of malignant tumours |
| 04/04/2007 | CN1942445A Novel quinoline-carbaxamides as JACK3 kinase modulators |
| 04/04/2007 | CN1942436A Lysine based compounds |
| 04/04/2007 | CN1942428A CETP inhibitors |
| 04/04/2007 | CN1939884A Novel aromatic compound and organic electroluminescnet element containing the same |
| 04/04/2007 | CN1308311C Novel pyridine- and quinoline-derivatives |
| 04/04/2007 | CN1308310C Nitrogenous aromatic ring compounds |
| 04/03/2007 | US7199392 Electroluminescent iridium compounds with fluorinated phenylpyridines, phenylprimidines, and phenylquinolines and devices made with such compounds |
| 04/03/2007 | US7199265 Thyroid receptor ligands, pharmaceutical compositions comprising them and their use in the treatment of disorders influenced by thyroid hormones |
| 04/03/2007 | US7199244 Cyclic amine derivatives and methods of use |
| 04/03/2007 | US7199134 Hydroxamic acid compounds and methods of use thereof |
| 04/03/2007 | US7198732 Rare earth metal compounds having at least one lanthanide metal and a 2-hydroxyquinoline-4-carboxylic acid |
| 03/29/2007 | WO2007035158A1 Alkyl sulfoxide quinolines as nk-3 receptor ligands |
| 03/29/2007 | WO2007035157A1 Alkylnitrile quinolines, as nk-3 receptor ligands |
| 03/29/2007 | WO2007035156A1 N-oxo-heterocycle and n-oxo-alkyl quinoline-4-carboxamides as nk-3 receptor ligands |
| 03/29/2007 | WO2007014941A3 Quinoline derivatives as antibacterial agents |
| 03/29/2007 | WO2007014940A3 Quinoline derivatives as antibacterical agents |
| 03/29/2007 | WO2007014940A2 Quinoline derivatives as antibacterical agents |
| 03/29/2007 | WO2007002635A3 C-linked cyclic antagonists of p2y1 receptor useful in the treatment of thrombotic conditions |
| 03/29/2007 | WO2006120478A3 Quinoline derivatives as neurokinin receptor antagonists |
| 03/29/2007 | US20070072884 agricultural and horticultural fungal infections of plants; novel N-alkynyl-2-quinolin-(isoquinolin- and quinazolin-)oxyalkylamides; 2-(6-quinolinyloxy)-N-(4-methylpent-2-yn-4-yl) butyramide |
| 03/29/2007 | US20070072868 Novel synthesis of gatifloxacin |
| 03/29/2007 | US20070072844 Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 03/29/2007 | US20070072842 6-Alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adpribose) polymerase inhibitors |
| 03/29/2007 | US20070072837 Histamine receptor antagonists; 4-[3-(4-Piperidin-1-yl-but-1-ynyl)-benzyl]-thiomorpholine; antiallergens, antihistamines, antiepileptic agents; asthma, alzheimer's disease, narcolepsy, motion sickness, attention deficit disorder, schizophrenia |
| 03/29/2007 | CA2800945A1 Methods and compositions for stimulating neurogenesis and inhibiting neuronal degeneration |
| 03/29/2007 | CA2621062A1 Alkyl sulfoxide quinolines as nk-3 receptor ligands |
| 03/29/2007 | CA2615897A1 Compounds and methods for treatment of amyloid-beta-peptide related disorders |
| 03/28/2007 | EP1767536A1 Quinolone carboxylic acid derivatives, thereof preparation and usage |
| 03/28/2007 | EP1765795A2 Alkynyl derivatives as modulators of metabotropic glutamate receptors |
| 03/28/2007 | EP1765782A1 Method of making 7-(4-bromobutoxy)-3,4-dihydrocarbostyril |
| 03/28/2007 | EP1765347A2 Compounds having activity in increasing ion transport by mutant-cftr and uses thereof |
| 03/28/2007 | CN1938314A Tetrahydroquinoline derivatives and a process for preparing the same |
| 03/28/2007 | CN1938266A Sulfonamide compounds for the treatment of neurodegenerative disorders |
| 03/28/2007 | CN1935791A Method for preparing 3-methyl quinolines-8-sulfochlorides |
| 03/28/2007 | CN1307175C Triazolo-quinolin derivatives useful as adenosine receptor ligands |
| 03/28/2007 | CN1307174C Imidazoquinoline derivatives |
| 03/28/2007 | CN1307160C Process for producing 2,3,6-trialkyl-8-fluoro-4-quinoline derivative |
| 03/28/2007 | CN1307159C TNF-alpha prodn. inhibitors |
| 03/27/2007 | US7196198 For therapy and prophylaxis of bone diseases, cancer, systemic granuloma, immunological diseases, allergy, atopy, asthma, gumboil, gingivitis, periodontitis, neurocyte death, Alzheimer's diseases, lungs injury, pulmopathy, acute hepatitis |
| 03/27/2007 | US7196102 Osteoporosis, bone disorders, or diseases associated with excessive secretion of PTH, such as hyperparathyroidism; reduce or inhibit parathyroid hormone (PTH) secretion |
| 03/27/2007 | CA2326611C Substituted heterocyclic derivatives |
| 03/22/2007 | WO2007032556A1 Novel 1-2-dihydroquinoline derivative having glucocorticoid receptor binding activity |
| 03/22/2007 | WO2007031429A1 Novel heterobicyclic derivatives useful as inhibitors of liver carnitine palmitoyl transferase |
| 03/22/2007 | WO2006105127A3 Hydroxysteroid dehydrogenase inhibitors |
| 03/22/2007 | US20070066825 Chiral ligands and their transition metal complexes |
| 03/22/2007 | US20070066650 (R)-6-(2-(2,2,2-Trifluoroethyl)-1-pyrrolidinyl)-4-trifluoromethyl-2(1H)-quinolinone; partial agonist, agonist or antagonist of androgen receptor; cachexia and wasting diseases; male-pattern baldness; benign prostatic hyperplasia; hirsutism; acne |
| 03/22/2007 | US20070066623 Entry inhibitors of the hiv virus |
| 03/22/2007 | US20070066607 5-[R-2-(1S,2S-2-Cyclohexylcyclopentylamino)-1-hydroxyethyl]-8-hydroxy-1H-quinolin-2-one, useful for treating conditions that are prevented or alleviated by activation of the adrenergic recptors |
| 03/22/2007 | US20070066600 Compounds |
| 03/22/2007 | US20070066599 New compounds |
| 03/22/2007 | US20070066598 Compounds |
| 03/22/2007 | US20070066586 Aniline derivatives |
| 03/22/2007 | US20070066575 Methods and compositions for mitigating pain |
| 03/22/2007 | CA2621292A1 1-2-dihydroquinoline derivative having glucocorticoid receptor binding actvity |
| 03/21/2007 | EP1764358A2 Cyclic amides as vanilloid receptor ligands and their use in treatments of inflammatory and neuropathic pain |
| 03/21/2007 | EP1764357A1 Selective androgen receptor modulators and methods of use thereof |
| 03/21/2007 | EP1763527A1 4-substituted quinoline derivatives, method and intermediates for preparing same and pharmaceutical compositions containing same |
| 03/21/2007 | EP1763382A1 2-oxy-acetamide compound, the uses thereof and compositions for stimulating or inducing the growth, and/or retarding the loss, of keratin fibres |
| 03/21/2007 | EP1453801B1 Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors |
| 03/21/2007 | CN1934086A Amine salt of carbostyril derivative |
| 03/21/2007 | CN1933839A Compounds and methods of use |
| 03/21/2007 | CN1305853C Process for the manufacture of HMG-coa reductase inhibitors |
| 03/21/2007 | CN1305475C Boronic ester and acid compounds, synthesis and uses |
| 03/21/2007 | CN1305472C Medical compsns. against helicobacter pylori |
| 03/20/2007 | US7193086 Process for preparation of a quinolinecarbaldehyde |
| 03/20/2007 | US7192982 Modulators of peroxisome proliferator activated receptors |
| 03/20/2007 | US7192971 4-Heteroaryl-tetrahydroquinolines and their use as inhibitors of the cholesterin-ester transfer protein |
| 03/20/2007 | US7192970 Noncyclic 1,3-dicarbonyl compounds as dual PPAR agonists with potent antihyperglycemic and antihyperlipidemic activity |
| 03/20/2007 | US7192961 1-Carbonyl-4-(4-quinoline-)-piperazine or 1-carbonyl-4-[4-(1H-quinolin-2-{thio}one)-piperazine derivatives; retinopathy, adult respiratory distress syndrome, asthma, osteoarthritis, glomerulonephritis, psoriasis, rheumatoid arthritis, and toxic shock syndrome treatment |
| 03/20/2007 | US7192955 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 03/15/2007 | WO2007030780A2 Quinoline derivatives and use as antitumor agents |
| 03/15/2007 | WO2007029036A2 Amino acid derivatives as histone deacetylase (hdac) inhibitors |
| 03/15/2007 | US20070060757 Selective hydrogenation of amino-substituted fused bicyclic aromatic ring system, preparation of racemic amino substituted fused bicyclic ring system via nitrosation, enzymatic resolution of racemic mixture to produce (R)- and (S)-forms |
| 03/15/2007 | US20070060748 Compounds with mixed pde-inhibitory and beta-adrenergic antagonist or partial agonist activity for treatment of heart failure |
| 03/15/2007 | US20070060624 Novel bioisosteres of actinonin |
| 03/15/2007 | US20070060612 Antitumor agents |
| 03/15/2007 | US20070060595 Novel fused heterocyclic compound and use thereof |
| 03/15/2007 | CA2621988A1 Quinoline derivatives and use as antitumor agents |
| 03/15/2007 | CA2621445A1 Amino acid derivatives as histone deacetylase (hdac) inhibitors |
| 03/14/2007 | EP1761486A1 Phenylcarboxylic acid derivatives and use thereof for the treatment of diabetes |
| 03/14/2007 | EP1761458A2 Molten salts, method of their production and process for generating hydrogen peroxide |